{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:08:06Z","timestamp":1775063286443,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.livres.2022.01.002","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T19:03:53Z","timestamp":1643483033000},"page":"50-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American liver Society\/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021"],"prefix":"10.1016","volume":"6","author":[{"given":"Wen-Xing","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2022.01.002_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep4.1599","article-title":"The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007-2017","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2022.01.002_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/hep.31583","article-title":"Reducing the global burden of alcohol-associated liver disease: a blueprint for action","volume":"73","author":"Asrani","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","article-title":"Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes","volume":"150","author":"Nagy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.01.002_bib6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.01.002_bib7","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.3748\/wjg.v20.i36.12908","article-title":"New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases","volume":"20","author":"Williams","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2022.01.002_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut-liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.01.002_bib9","article-title":"Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22","volume":"118","author":"Wang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2022.01.002_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcmgh.2021.08.014","article-title":"Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease","volume":"13","author":"Qian","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib11","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.ajpath.2011.08.039","article-title":"Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury","volume":"179","author":"Wang","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2022.01.002_bib12","doi-asserted-by":"crossref","first-page":"42165","DOI":"10.1074\/jbc.M112.377374","article-title":"Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations","volume":"287","author":"Han","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2022.01.002_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40139-013-0021-z","article-title":"Role of mitochondria in alcoholic liver disease","volume":"1","author":"Garc\u00eda-Ruiz","year":"2013","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.livres.2022.01.002_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajpath.2018.11.008","article-title":"Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity","volume":"189","author":"Palma","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2022.01.002_bib15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3390\/cells9040837","article-title":"Role and mechanisms of mitophagy in liver diseases","volume":"9","author":"Ma","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.livres.2022.01.002_bib16","doi-asserted-by":"crossref","first-page":"G324","DOI":"10.1152\/ajpgi.00108.2015","article-title":"Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice","volume":"309","author":"Williams","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.01.002_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ajpath.2021.10.004","article-title":"Loss of hepatic transcription factor EB attenuates alcohol-associated liver carcinogenesis","volume":"192","author":"Chao","year":"2022","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2022.01.002_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.livres.2022.01.002_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.amepre.2011.02.026","article-title":"Emergency department visits for overdoses of acetaminophen-containing products","volume":"40","author":"Budnitz","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.livres.2022.01.002_bib20","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1007\/s00204-019-02597-1","article-title":"Emerging and established modes of cell death during acetaminophen-induced liver injury","volume":"93","author":"Jaeschke","year":"2019","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.livres.2022.01.002_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI76887","article-title":"The HMGB1\/RAGE axis triggers neutrophil-mediated injury amplification following necrosis","volume":"125","author":"Huebener","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2022.01.002_bib22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/hep.29153","article-title":"Hepatic mitochondrial DNA\/Toll-like receptor 9\/MicroRNA-223 forms a negative feedback loop to limit neutrophil overactivation and acetaminophen hepatotoxicity in mice","volume":"66","author":"He","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.21779","article-title":"Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice","volume":"46","author":"Ganey","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib24","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/liv.13866","article-title":"Role and mechanisms of autophagy in acetaminophen-induced liver injury","volume":"38","author":"Chao","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2022.01.002_bib25","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1189\/jlb.0308173","article-title":"Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury","volume":"84","author":"Holt","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.livres.2022.01.002_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68571","article-title":"Chitinase 3-like-1 contributes to acetaminophen-induced liver injury by promoting hepatic platelet recruitment","volume":"10","author":"Shan","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.livres.2022.01.002_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hep.24690","article-title":"Activation of autophagy protects against acetaminophen-induced hepatotoxicity","volume":"55","author":"Ni","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhep.2016.04.025","article-title":"Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice","volume":"65","author":"Ni","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib29","doi-asserted-by":"crossref","first-page":"101148","DOI":"10.1016\/j.redox.2019.101148","article-title":"Double deletion of PINK1 and Parkin impairs hepatic mitophagy and exacerbates acetaminophen-induced liver injury in mice","volume":"22","author":"Wang","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.livres.2022.01.002_bib30","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41574-019-0266-7","article-title":"Bile acids in glucose metabolism and insulin signalling-mechanisms and research needs","volume":"15","author":"Ahmad","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.livres.2022.01.002_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hep.31652","article-title":"Bile acid profiles in primary sclerosing cholangitis and their ability to predict hepatic decompensation","volume":"74","author":"Mousa","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib32","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1002\/hep.32028","article-title":"Mast cells regulate ductular reaction and intestinal inflammation in cholestasis through farnesoid X receptor signaling","volume":"74","author":"Meadows","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165557","article-title":"Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage\/senescence and liver fibrosis in Mdr2-\/- mice","volume":"1865","author":"Meadows","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.livres.2022.01.002_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.29838","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans","volume":"68","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib35","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/hep.29145","article-title":"The role of long noncoding RNA H19 in gender disparity of cholestatic liver injury in multidrug resistance 2 gene knockout mice","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2022.01.002_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.livres.2019.02.003","article-title":"Sphingosine-1-phosphate signaling and the gut-liver axis in liver diseases","volume":"3","author":"Kwong","year":"2019","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2022.01.002_bib38","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s40495-017-0093-2","article-title":"Sphingosine kinases\/Sphingosine 1-phosphate signaling in hepatic lipid metabolism","volume":"3","author":"Kwong","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.livres.2022.01.002_bib39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1194\/jlr.R069286","article-title":"The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases","volume":"57","author":"Nagahashi","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.livres.2022.01.002_bib40","doi-asserted-by":"crossref","first-page":"s87","DOI":"10.5604\/01.3001.0010.5501","article-title":"Bile acids and cancer: direct and environmental-dependent effects","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.livres.2022.01.002_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.devcel.2018.12.021","article-title":"FGF15 activates Hippo signaling to suppress bile acid metabolism and liver tumorigenesis","volume":"48","author":"Ji","year":"2019","journal-title":"Dev Cell"},{"key":"10.1016\/j.livres.2022.01.002_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.livres.2022.01.002_bib45","doi-asserted-by":"crossref","first-page":"G549","DOI":"10.1152\/ajpgi.00152.2020","article-title":"Bile acid metabolism and circadian rhythms","volume":"319","author":"Yang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2022.01.002_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2022.01.002_bib47","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.01.002_bib48","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2021.09.040","article-title":"Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling","volume":"76","author":"Lan","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib51","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/s41591-018-0048-0","article-title":"Inactivating hepatic follistatin alleviates hyperglycemia","volume":"24","author":"Tao","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2022.01.002_bib52","doi-asserted-by":"crossref","first-page":"dgaa090","DOI":"10.1210\/clinem\/dgaa090","article-title":"Circulating Follistatin and Activin A and their regulation by Insulin in obesity and type 2 diabetes","volume":"105","author":"Sylow","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.livres.2022.01.002_bib53","doi-asserted-by":"crossref","first-page":"6678142","DOI":"10.1155\/2021\/6678142","article-title":"Association between nonalcoholic fatty liver disease and endocrinopathies: clinical implications","volume":"2021","author":"Singeap","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.01.002_bib55","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2022.01.002_bib56","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.livres.2022.01.002_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2022.01.002_bib58","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2020.11.036","article-title":"Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis","volume":"74","author":"Heinrich","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib59","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1126\/science.8096088","article-title":"SH2-containing phosphotyrosine phosphatase as a target of protein-tyrosine kinases","volume":"259","author":"Feng","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.livres.2022.01.002_bib60","doi-asserted-by":"crossref","first-page":"109974","DOI":"10.1016\/j.celrep.2021.109974","article-title":"Single-cell transcriptomics reveals opposing roles of Shp2 in Myc-driven liver tumor cells and microenvironment","volume":"37","author":"Chen","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.livres.2022.01.002_bib61","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2021.06.028","article-title":"Single-cell atlas of tumor cell evolution in response to therapy in hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"75","author":"Ma","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib62","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cmet.2019.01.002","article-title":"Inhibiting glutamine-dependent mTORC1 activation ameliorates liver cancers driven by \u03b2-Catenin mutations","volume":"29","author":"Adebayo Michael","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2022.01.002_bib63","first-page":"87","article-title":"Hepatocytic p62 suppresses ductular reaction and tumorigenesis in mouse livers with mTORC1 activation and defective autophagy","volume":"192","author":"Chao","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2022.01.002_bib64","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2021.04.053","article-title":"Dual and opposing roles of the androgen receptor in VETC-dependent and invasion-dependent metastasis of hepatocellular carcinoma","volume":"75","author":"Zhou","year":"2021","journal-title":"J\u00a0Hepatol"}],"updated-by":[{"DOI":"10.1016\/j.livres.2023.08.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568422000022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:32Z","timestamp":1762872392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568422000022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2542568422000022"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2022.01.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American liver Society\/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2022.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}